DOSAGE AND ADMINISTRATION
The recommended doses of ANZEMET Tablets should not be exceeded.
Prevention of Cancer Chemotherapy-Induced Nausea and Vomiting
Adults
The recommended oral dosage of ANZEMET (dolasetron mesylate) is 100 mg given within one hour before chemotherapy.
Pediatric Patients
The recommended oral dosage in pediatric patients 2 to 16 years of age is 1.8 mg/kg given within one hour before chemotherapy, up to a maximum of 100 mg. Safety and effectiveness in pediatric patients under 2 years of age have not been established.
Use in the Elderly, Renal Failure Patients, or Hepatically Impaired Patients
No dosage adjustment is recommended. (See Pharmacokinetics in Humans.)
Prevention of Postoperative Nausea and Vomiting
Adults
The recommended oral dosage of ANZEMET (dolasetron mesylate) is 100 mg within two hours before surgery.
Pediatric Patients
The recommended oral dosage in pediatric patients 2 to 16 years of age is 1.2 mg/kg given within two hours before surgery, up to a maximum of 100 mg. Safety and effectiveness in pediatric patients under 2 years of age have not been established.
Use in the Elderly, Renal Failure Patients, or Hepatically Impaired Patients
No dosage adjustment is recommended. (See Pharmacokinetics in Humans.)
|